Protocol for Improvement of Therapy With Warfarin

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

October 21, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Atrial Fibrillation (AF)
Interventions
DRUG

pharmacogenetic algorithm

The dose predictor algorithm proposed in this work aims to maintain and quality treatment in an individualized and effective manner. In the routine use protocol, warfarin is prescribed based only on the INR collected within 5 days. The proposed intervention protocol is based on the patient's clinical and genetic factors, such as genetic polymorphisms, age, weight, height, race, use of amiodarone, statins, antifungals or antibiotics, tobacco use, clinical indication and what the RNI target.

DRUG

Clinical treatment

Patients with AF indicated for OAC therapy guided by institutional protocol.

Trial Locations (1)

50100-010

University of Pernambuco, Recife

All Listed Sponsors
collaborator

Universidade Federal de Pernambuco

OTHER

lead

University of Pernambuco

OTHER